Salesforce's 15-minute chart has recently triggered a MACD Death Cross and a KDJ Death Cross at 07/18/2025 12:30. This indicates that the stock price has the potential to continue declining, with a shifting momentum towards the downside and a potential for further decreases.
Salesforce's (CRM) 15-minute chart has recently exhibited a MACD Death Cross and a KDJ Death Cross on July 18, 2025, at 12:30. This technical analysis suggests that the stock price may continue to decline, with a shifting momentum towards the downside and a potential for further decreases.
The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, indicating a bearish trend. The KDJ (Kijun-Sen, Tenkan-Sen, Jikou-Sen) Death Cross, on the other hand, occurs when the K line crosses below the D line, signaling a shift in momentum from bullish to bearish. Together, these patterns suggest that Salesforce's stock may experience a prolonged downward trend [1].
Salesforce, a leading provider of customer relationship management (CRM) software, has been a dominant player in the tech sector. However, despite its strong market position, the stock has underperformed relative to the broader market indices. Over the past 52 weeks, CRM has experienced a 6.5% decline, lagging behind the S&P 500 Index's 11.7% rise and the Technology Select Sector SPDR Fund’s 10.8% return [2].
Salesforce's recent financial performance has been mixed. The company reported a 2.8% increase in revenue for the first quarter of fiscal 2025, but this was accompanied by a 1.4% decrease in net income. The company's core FFO (Funds from Operations) per share was $2.37, down 0.9% year-over-year [2].
Looking ahead, Salesforce has guided for a 2.5% increase in FFO per share for fiscal 2025, with expectations for continued growth in cloud-based services. However, the stock's recent technical indicators suggest that investors may need to exercise caution. Wall Street analysts are generally neutral on CRM, with a "Hold" rating overall. Among 29 analysts covering the stock, 17 recommend "Hold," 10 suggest "Sell," and 2 advise "Strong Sell” rating. The mean price target for CRM is $320.00, indicating a 1.9% potential downside from the current levels [2].
Institutional investors have also shown a mixed sentiment towards CRM. Over the first quarter, several major institutional investors, including Vanguard Group and BlackRock, have reduced their stakes in CRM. However, some hedge funds, such as Tiger Global Management and Elliott Management, have increased their positions in the stock [3].
Despite the recent technical indicators, Salesforce's strong brand and market leadership position may provide support for the stock. However, investors should remain vigilant and monitor the company's financial performance and technical indicators closely.
References:
[1] https://www.ainvest.com/news/salesforce-15min-chart-sees-macd-death-cross-kdj-death-cross-signal-2507-83/
[2] https://www.nasdaq.com/articles/salesforce-stock-gains-126-three-months-will-trend-last
[3] https://www.marketbeat.com/instant-alerts/filing-vanguard-group-reduces-position-in-salesforce-inc-nyse-crm-2025-07-15/
Comments
No comments yet